Phase II Trial of FOLFOXIRI Plus Panitumumab as First-Line Treatment for Kras and Braf Wild-Type Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Fluorouracil; Folinic acid; Irindalone; Irinotecan; Oxaliplatin; Panitumumab
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms TRIP
- 07 Jun 2016 Results (n=784) of pooled analysis of 6 trials (GONO-FOLFOXIRI , FOIB, TRIP, TRIBE, MACBETH and MOMA) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 05 Oct 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 17 Mar 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2009-014556-29).